Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9044008 | 0.75 | DPP4 (0.48) | VNN1HPGDADORA2BADORA2AHDAC4 | |
| SCHEMBL3715622 | 0.75 | POLB (0.43) | HPGDAPOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL9044128 | 0.73 | VNN1 (0.40) | VNN1HPGDADORA2BADORA2AHDAC4 | |
| SCHEMBL3716813 | 0.70 | ALDH1A1 (0.44) | — | |
| SCHEMBL4053920 | 0.67 | HDAC4 (0.48) | VNN1HDAC4 | |
| SCHEMBL28089590 | 0.67 | HDAC4 (0.48) | VNN1HDAC4 | |
| SCHEMBL4458413 | 0.67 | PDK2 (0.43) | VNN1HPGDADORA2BHDAC4RAB9A | |
| SCHEMBL7381076 | 0.67 | L3MBTL1 (0.66) | VNN1KMT2A | |
| SCHEMBL29688509 | 0.67 | L3MBTL1 (0.66) | VNN1KMT2A | |
| SCHEMBL8924724 | 0.66 | KDM4E (0.41) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010131145-A1 | CYCLOBUTENEDIONE DERIVATIVES | PFIZER LIMITED (GB) | 2010-11-18 | — | — | WO | disclosed |